Full Press Release Details
dupixent dupilumab approved as the first ever biologic medicine in japan for patients with chronic obstructive pulmonary disease copd.
REGN
dupixent dupilumab approved as the first ever biologic medicine in japan for patients with chronic obstructive pulmonary disease copd
Key Takeaway: dupixent dupilumab approved as the first ever biologic medicine in japan for patients with chronic obstructive pulmonary disease copd